Propiedad y actividad de insiders de Immunovant, Inc. (IMVT): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $36.38 |
| Capitalización | $7.5B |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | 0 | $325000 | $100.6M | $400.1M | $493.8M | $376.5M | $635.4M | $714.0M | $902.1M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | $3.0M | $1.1M | $12.9M | $885000 | $5.5M | $2.5M | $3.9M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $113170 | $325000 | $109.1M | $409.0M | $512.9M | $404.3M | $665.8M | $767.7M | $948.8M |
| Inmovilizado Material | 0 | 0 | $65000 | $3.5M | $2.6M | $1.5M | $595000 | $942000 | $515000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $113170 | $405000 | $109.4M | $412.5M | $515.6M | $405.8M | $666.7M | $776.2M | $957.6M |
| Cuentas por Pagar | $1.1M | 0 | $1.2M | $2.4M | $18.6M | $1.4M | $7.2M | $17.7M | $7.5M |
| Deuda a Corto | 0 | $300000 | $3.2M | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $1.6M | $380448 | $15.3M | $18.8M | $44.5M | $43.3M | $48.6M | $68.8M | $104.4M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.6M | $380448 | $15.3M | $21.0M | $45.7M | $43.3M | $49.0M | $68.8M | $105.0M |
| Reservas | 0 | -$448 | -$91.2M | -$198.7M | -$355.4M | -$566.3M | -$825.7M | -$1.24B | -$1.75B |
| Patrimonio Neto | -$1.5M | $24552 | $94.1M | $391.5M | $469.8M | $362.5M | $617.8M | $707.4M | $852.6M |
| Deuda Total | 0 | $300000 | $3.2M | $3.4M | $2.4M | $1.2M | $138000 | $98000 | $72000 |
| Deuda Neta | 0 | -$25000 | -$97.4M | -$396.7M | -$491.5M | -$375.3M | -$635.2M | -$713.9M | -$902.0M |
| Capital Circulante | -$1.5M | -$55448 | $93.8M | $390.2M | $468.4M | $361.0M | $617.2M | $698.9M | $844.4M |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 7.27 |
Rentabilidad
| Margen bruto | 97.10% |
| Margen operativo | -7877.46% |
| Margen neto | -7585.86% |
Empresas relacionadas: ACAD · AKRO · CRNX · DYN · KYMR · NAMS · PRAX
Explorar sector: Healthcare · Biotechnology
Más secciones de IMVT: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones